ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline

Ann Surg Oncol. 2020 Aug;27(8):2972-2973. doi: 10.1245/s10434-020-08299-8. Epub 2020 Mar 2.

Authors

Alessandro Paniccia¹, Amer Zureikat²

Affiliations

¹ Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. panicciaa2@upmc.edu.
² Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.

PMID: 32124127
DOI: 10.1245/s10434-020-08299-8

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use*
Carcinoma, Pancreatic Ductal* / drug therapy
Carcinoma, Pancreatic Ductal* / surgery
Disease Progression
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms* / drug therapy
Pancreatic Neoplasms* / surgery

Substances

Antineoplastic Agents